Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More Advocacy at a Glance STEVEN GROSSMAN 7/10/20 Advocacy at a Glance STEVEN GROSSMAN 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More
Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More
Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More
Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More
Advocacy at a Glance STEVEN GROSSMAN 7/10/20 Advocacy at a Glance STEVEN GROSSMAN 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More
Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More
